Samit Hirawat - Net Worth and Insider Trading

Samit Hirawat Net Worth

The estimated net worth of Samit Hirawat is at least $3 Million dollars as of 2025-04-28. Samit Hirawat is the EVP,Chief Med.Offr.,Drug Dev. of Bristol-Myers Squibb Co and owns about 63,932 shares of Bristol-Myers Squibb Co (BMY) stock worth over $3 Million. Details can be seen in Samit Hirawat's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Samit Hirawat has not made any transactions after 2025-02-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Samit Hirawat

To

Samit Hirawat Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samit Hirawat owns 1 companies in total, including Bristol-Myers Squibb Co (BMY) .

Click here to see the complete history of Samit Hirawat’s form 4 insider trades.

Insider Ownership Summary of Samit Hirawat

Ticker Company Transaction Date Type of Owner
BMY Bristol-Myers Squibb Co 2025-02-14 Chief Medical Offr. & Drug Dev.

Samit Hirawat Latest Holdings Summary

Samit Hirawat currently owns a total of 1 stock. Samit Hirawat owns 63,932 shares of Bristol-Myers Squibb Co (BMY) as of February 14, 2025, with a value of $3 Million.

Latest Holdings of Samit Hirawat

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMY Bristol-Myers Squibb Co 2025-02-14 63,932 48.27 3,085,998

Holding Weightings of Samit Hirawat


Samit Hirawat Form 4 Trading Tracker

According to the SEC Form 4 filings, Samit Hirawat has made a total of 2 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Bristol-Myers Squibb Co is the acquisition of 1,823 shares on February 14, 2025, which cost Samit Hirawat around $100,000.

Insider Trading History of Samit Hirawat

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samit Hirawat Trading Performance

GuruFocus tracks the stock performance after each of Samit Hirawat's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samit Hirawat is 8.52%. GuruFocus also compares Samit Hirawat's trading performance to market benchmark return within the same time period. The performance of stocks bought by Samit Hirawat within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samit Hirawat's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samit Hirawat

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.25 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.49 LIMIT LIMIT LIMIT LIMIT LIMIT

Samit Hirawat Ownership Network

Ownership Network List of Samit Hirawat

No Data

Ownership Network Relation of Samit Hirawat

Insider Network Chart

Samit Hirawat Owned Company Details

What does Bristol-Myers Squibb Co do?

Who are the key executives at Bristol-Myers Squibb Co?

Samit Hirawat is the Chief Medical Offr. & Drug Dev. of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .

Bristol-Myers Squibb Co (BMY) Insider Trades Summary

Over the past 18 months, Samit Hirawat made 2 insider transaction in Bristol-Myers Squibb Co (BMY) with a net purchase of 3,653. Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net purchase of 7,071 shares made by Christopher S. Boerner , a net purchase of 8,500 shares made by Samuels Theodore R. Ii , and a net sale of 700 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 3,823 shares, with a net purchase of 3,823 shares. During the past 18 months, 700 shares of Bristol-Myers Squibb Co (BMY) were sold and 19,224 shares were bought by its insiders, resulting in a net purchase of 18,524 shares.

Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Bristol-Myers Squibb Co Insider Transactions

No Available Data

Samit Hirawat Mailing Address

Above is the net worth, insider trading, and ownership report for Samit Hirawat. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Samit Hirawat's mailing address is: Princeton Nj 08543.